HOUSTON, Dec. 7 /PRNewswire/ -- The Brainwaves Neuroimaging Clinic (http://www.brainwavesnic.com/) has announced it is introducing the first biologically based tool for the aid in assessment of AD/HD in the Houston area. The DataLex Indicator Report(SM) for AD/HD from Lexicor, Inc. (http://www.lexicor.com/) uses brainwave technology to finally help answer the question, “does my child have attention deficit disorder?”
AD/HD is a disorder of the brain associated with lack of impulse control, inattention and other behavior problems. It affects an estimated 7 to 10 percent of school-age children and an estimated 4 percent of all adults.
“The DataLex(SM) report offers our facility a new and crucial first step in the evaluation of AD/HD,” said Dr. Lisa C. Routh, child and adult psychiatrist and executive director of Brainwaves Neuroimaging Clinic. “It’s an amazing new tool that complements our existing AD/HD assessment process and allows us to more clearly identify patients with AD/HD. DataLex(SM) also lets us more clearly identify those without AD/HD, but who have other disorders that our center can evaluate using our SPECT functional brain imaging technology.”
The DataLex Indicator Report(SM) for AD/HD complements the patient history and medical examination, and is combined with a physician’s expert evaluation to lead to a more accurate assessment of AD/HD. The Brainwaves Neuroimaging Clinic also offers brain SPECT imaging for the visualization of brain blood flow and metabolism, which can assist in the diagnosis of traumatic brain injury, depression and other mental conditions.
The DataLex(SM) report uses patient brain wave data collected using non-invasive, quantitative electroencephalogram (qEEG) technology. The report is based upon scientific research that shows AD/HD patients have distinct brain activity patterns compared to the general population. The report can classify those with AD/HD to an accuracy of 90 percent and identify those who do not have AD/HD to an accuracy of 94 percent.
Data is collected using a sensor-filled cap to measure the electrical patterns of the brain and takes about an hour to complete. Once collected, the qEEG data is sent to Lexicor for analysis and a DataLex(SM)report is generated. The report is an evaluation aid for physicians-not a specific diagnostic test.
The DataLex(SM) report is covered by most insurance companies and is currently offered at the Brainwaves Neuroimaging Clinic. To make an appointment or for more information, call 713-796-0022. For more information about using the Datalex report in your practice, call 832-630-2258.
About The Brainwaves Neuroimaging Clinic
Lisa C. Routh, MD is a child and adult psychiatrist, brain imaging specialist and the executive director of Brainwaves Neuroimaging Clinic in Houston, Texas. She is a nationally recognized expert in the fields of neuropsychiatry, women’s issues, attention deficit disorders and psychopharmacology. Please contact the Brainwaves Neuroimaging Clinic office at 713-796-0022 to schedule an appointment for the DataLex AD/HD, SPECT imaging and other evaluation services. For more information, visit http://www.brainwavesnic.com/
About Lexicor’s DataLex Indicator Report(SM) for AD/HD
For more than 13 years, Lexicor has been the leader in the field of digital EEG data collection, management and analysis. Through extensive research, development and improvements, Lexicor has developed the quantitative EEG data analysis service called the DataLex Indicator Report(SM). The DataLex Indicator Report(SM) assists physicians in reaching a more accurate assessment of AD/HD. Physicians use standard cleared EEG collection devices for qEEG data collection. For more information, contact Lexicor at 1-888-LEXICOR (539-4267) or visit http://www.lexicor.com/.
Lexicor, Inc.
CONTACT: Dan Snyders of Armada Medical Marketing,+1-303-623-1190, ext. 230, dan@armadamedical.com, for Lexicor, Inc.
Web site: http://www.brainwavesnic.com/
Web site: http://www.lexicor.org/